GlassScriptPhysician profile
Carlton S Pearse
NPI 1457358582
$581.56
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $28.88 · 2021: $29.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $146.07 | 2019 | |
| Amgen INC. | $144.84 | 2019 | |
| Abbvie INC. | $55.38 | 2019 | |
| Hologic Sales and Service, LLC | $41.58 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.04 | 2019 | |
| Merck Sharp & Dohme LLC | $30.67 | 2019-2020 | |
| Ethicon US, LLC | $30.46 | 2019-2021 | |
| Pfizer INC. | $24.54 | 2019 | |
| Organon LLC | $16.83 | 2021 | |
| Avion Pharmaceuticals | $14.28 | 2020 | |
| Roche Diagnostics Corporation | $14.17 | 2019 | |
| Astellas Pharma US INC | $13.16 | 2019 | |
| Smith+Nephew, INC. | $12.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlton Pearse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.